These findings suggest that the pattern of dopamine transporter uptake could serve as a valuable biomarker for frontotemporal dementia, shedding light on the role of the dopaminergic system and the striatum in some fundamental clinical aspects. This evidence concerns the gene SLC6A3 and frontotemporal dementia.